United Guardian (UG) Operating Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
United Guardian (UG) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.92 Bn | 626.16 Bn | 17.26 Bn |
| 2 | AbbVie | 441.93 Bn | 435.36 Bn | 12.70 Bn |
| 3 | Merck | 365.88 Bn | 358.74 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.44 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 8 | Incyte | 25.31 Bn | 20.78 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.45 Bn | 18.78 Bn | 683.80 Mn |
| 10 | United Guardian | 32.73 Mn | 23.14 Mn | 1.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,717.00 |
| Mar 31, 2026 | -2,207.00 |
| Dec 31, 2025 | 296.00 |
| Sep 30, 2025 | -2,275.00 |
| Jun 30, 2025 | -1,151.00 |
| Mar 31, 2025 | -1,482.00 |
| Dec 31, 2024 | 3,938.00 |
| Sep 30, 2024 | -761.00 |
| Jun 30, 2024 | -420.00 |
| Mar 31, 2024 | -765.00 |
| Dec 31, 2023 | -147.00 |
| Sep 30, 2023 | -2,212.00 |
| Jun 30, 2023 | -2,480.00 |
| Mar 31, 2023 | -863.00 |
| Dec 31, 2022 | -1,895.00 |
| Sep 30, 2022 | -1,778.00 |
| Jun 30, 2022 | -746.00 |
| Mar 31, 2022 | 745.00 |
| Dec 31, 2021 | 681.00 |
| Sep 30, 2021 | 506.00 |